Andelyn Biosciences

Andelyn Biosciences Expands AAV Curator™ Platform Offering to Include Stanton Lab CNS Capsids through a License Agreement from the Broad Institute of MIT and Harvard

18 February 2025 – Columbus, OH, US – Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has expanded its AAV Curator™ Platform offering and License Agreement with the Broad Institute of MIT and Harvard to include the Stanton Lab CNS (Central Nervous System) capsids. Developed by...
1180 Arthur E. Adams Drive Columbus, OH 43221


1-844-AAV-CDMO